Clinical Trials Directory

Trials / Completed

CompletedNCT01507363

Analgesic Effect of Gabapentin in Total Knee Arthroplasty (TKA)

Analgesic Effect of Perioperative Gabapentin in Total Knee Arthroplasty: A Randomized, Double-blind, Placebo-controlled, Dose-response Study

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
300 (actual)
Sponsor
Hvidovre University Hospital · Academic / Other
Sex
All
Age
50 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Pain is a major problem after TKA. Gabapentin may reduce acute postoperative pain. The investigators therefore investigate the effect of Gabapentin as a perioperative analgesic.

Detailed description

Pain is a major problem after TKA. Studies indicate that Gabapentin may reduce acute postoperative pain. However, the optimal dose is unknown and there is constant controversy on analgesic versus side-effects. The investigators therefore investigate the effect of Gabapentin as a perioperative analgesic in a dose-related manner and with a sample-size allowing evaluation of side-effects.

Conditions

Interventions

TypeNameDescription
DRUGGabapentinTables with Gabapentin (1300 mg/ day) for 7 days, starting on the day of surgery
DRUGGabapentinTables with Gabapentin (900 mg/day) for 7 days, starting on the day of surgery
DRUGPlaceboPlacebo tablets for 7 days, starting on the day of surgery

Timeline

Start date
2012-01-01
Primary completion
2013-11-01
Completion
2013-11-01
First posted
2012-01-10
Last updated
2014-04-11

Locations

3 sites across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01507363. Inclusion in this directory is not an endorsement.

Analgesic Effect of Gabapentin in Total Knee Arthroplasty (TKA) (NCT01507363) · Clinical Trials Directory